During the past decade, Hospital Dr. Sotero del Rio conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 15 clinical trials were completed, i.e. on average, 136.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Dr. Sotero del Rio" #1 sponsor was "Baxalta now part of Shire" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "MedImmune LLC" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Pontificia Universidad Catolica de Chile" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Dr. Sotero del Rio" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Dr. Sotero del Rio" are "Hemophilia B" (3 trials), "Respiratory Distress Syndrome" (3 trials), "Respiratory Syncytial Virus Infections" (3 trials), "Cardiovascular Disease" (2 trials) and "HIV Infections" (2 trials). Many other conditions were trialed in "Hospital Dr. Sotero del Rio" in a lesser frequency.

Most popular intervention types in "Hospital Dr. Sotero del Rio" are "Drug" (20 trials), "Biological" (9 trials), "Device" (4 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Atazanavir" (2 trials), "Etrasimod" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "motavizumab (MEDI-524)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Dr. Sotero del Rio" are 36 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Dr. Sotero del Rio". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Hospital Dr. Sotero del Rio, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Dr. Sotero del Rio, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".